233 related articles for article (PubMed ID: 26674820)
1. Low-dose continuous infusion of factor VIII in patients with haemophilia A.
Prelog T; Dolničar MB; Kitanovski L
Blood Transfus; 2016 Sep; 14(5):474-80. PubMed ID: 26674820
[TBL] [Abstract][Full Text] [Related]
2. Perioperative continuous infusions of factor VIII versus factor IX for patients with hemophilia A or B undergoing major surgery.
Tse B; Nisenbaum R; Floros G; Jiwajee A; Teitel J; Sholzberg M
J Thromb Thrombolysis; 2023 Feb; 55(2):273-281. PubMed ID: 36547766
[TBL] [Abstract][Full Text] [Related]
3. Surgical evaluation of a recombinant factor VIII prepared using a plasma/albumin-free method: efficacy and safety of Advate in previously treated patients.
Négrier C; Shapiro A; Berntorp E; Pabinger I; Tarantino M; Retzios A; Schroth P; Ewenstein B
Thromb Haemost; 2008 Aug; 100(2):217-23. PubMed ID: 18690340
[TBL] [Abstract][Full Text] [Related]
4. Continuous infusion of factor concentrates in children with haemophilia A in comparison with bolus injections.
Bidlingmaier C; Deml MM; Kurnik K
Haemophilia; 2006 May; 12(3):212-7. PubMed ID: 16643203
[TBL] [Abstract][Full Text] [Related]
5. Continuous infusion during total joint arthroplasty in Japanese haemophilia A patients: comparison study among two recombinants and one plasma-derived factor VIII.
Takedani H
Haemophilia; 2010 Sep; 16(5):740-6. PubMed ID: 20398072
[TBL] [Abstract][Full Text] [Related]
6. Continuous intravenous infusion of a plasma-derived factor IX concentrate (Mononine) in haemophilia B.
Hoots WK; Leissinger C; Stabler S; Schwartz BA; White G; Dasani H; Massion C; Negrier C; Schindel F; Schulman S
Haemophilia; 2003 Mar; 9(2):164-72. PubMed ID: 12614367
[TBL] [Abstract][Full Text] [Related]
7. Continuous and intermittent infusion of coagulation factor concentrates in patients undergoing surgery: a single centre Australian experience.
Campbell PJ; Rickard KA
Aust N Z J Med; 1998 Aug; 28(4):440-5. PubMed ID: 9777111
[TBL] [Abstract][Full Text] [Related]
8. European retrospective study of real-life haemophilia treatment.
Berntorp E; Dolan G; Hay C; Linari S; Santagostino E; Tosetto A; Castaman G; Álvarez-Román MT; Parra Lopez R; Oldenburg J; Albert T; Scholz U; Holmström M; Schved JF; Trossaërt M; Hermans C; Boban A; Ludlam C; Lethagen S
Haemophilia; 2017 Jan; 23(1):105-114. PubMed ID: 27761962
[TBL] [Abstract][Full Text] [Related]
9. Continuous infusion of recombinant factor VIII formulated with sucrose in surgery: non-interventional, observational study in patients with severe haemophilia A.
Meijer K; Rauchensteiner S; Santagostino E; Platokouki H; Schutgens RE; Brunn M; Tueckmantel C; Valeri F; Schinco PC
Haemophilia; 2015 Jan; 21(1):e19-25. PubMed ID: 25458982
[TBL] [Abstract][Full Text] [Related]
10. Continuous infusion of intermediate-purity factor VIII in haemophilia A patients undergoing elective surgery.
Rochat C; McFadyen ML; Schwyzer R; Gillham A; Cruickshank A
Haemophilia; 1999 May; 5(3):181-6. PubMed ID: 10444285
[TBL] [Abstract][Full Text] [Related]
11. Intermittent injections vs. continuous infusion of factor VIII in haemophilia patients undergoing major surgery.
Batorova A; Martinowitz U
Br J Haematol; 2000 Sep; 110(3):715-20. PubMed ID: 10997985
[TBL] [Abstract][Full Text] [Related]
12. Continuous infusion in haemophilia: current practice in Europe.
Batorova A; Holme P; Gringeri A; Richards M; Hermans C; Altisent C; Lopez-Fernández M; Fijnvandraat K;
Haemophilia; 2012 Sep; 18(5):753-9. PubMed ID: 22530687
[TBL] [Abstract][Full Text] [Related]
13. Comparing bleed frequency and factor concentrate use between haemophilia A and B patients.
Nagel K; Walker I; Decker K; Chan AK; Pai MK
Haemophilia; 2011 Nov; 17(6):872-4. PubMed ID: 21342368
[TBL] [Abstract][Full Text] [Related]
14. Continuous infusion of B-domain deleted recombinant factor VIII (ReFacto) in patients with haemophilia A undergoing surgery: clinical experience.
Stieltjes N; Altisent C; Auerswald G; Négrier C; Pouzol P; Reynaud J; Roussel-Robert V; Savidge GF; Villar A; Schulman S
Haemophilia; 2004 Sep; 10(5):452-8. PubMed ID: 15357770
[TBL] [Abstract][Full Text] [Related]
15. [Haemophilia A and haemophilia B. Are there relevant clinical differences?].
Klamroth R; Orlovic M; Kubicek-Hofman C; Gottstein S
Hamostaseologie; 2010 Nov; 30 Suppl 1():S26-7. PubMed ID: 21042678
[TBL] [Abstract][Full Text] [Related]
16. Inhibitor incidence after intensive FVIII replacement for surgery in mild and moderate haemophilia A: a prospective national study in the Netherlands.
Eckhardt CL; Mauser-Bunschoten EP; Peters M; Leebeek FW; van der Meer FJ; Fijnvandraat K
Br J Haematol; 2012 Jun; 157(6):747-52. PubMed ID: 22533635
[TBL] [Abstract][Full Text] [Related]
17. Continuous factor VIII infusion therapy in patients with haemophilia A undergoing surgical procedures with plasma-derived or recombinant factor VIII concentrates.
Dingli D; Gastineau DA; Gilchrist GS; Nichols WL; Wilke JL
Haemophilia; 2002 Sep; 8(5):629-34. PubMed ID: 12199670
[TBL] [Abstract][Full Text] [Related]
18. Infection risk and stability of a continuous 8-h 250 mL rFVIII infusion.
Lambing A; Kuriakose P; Mueller LM
Haemophilia; 2014 Mar; 20(2):212-8. PubMed ID: 24251950
[TBL] [Abstract][Full Text] [Related]
19. Clot waveform analysis using CS-2000i™ distinguishes between very low and absent levels of factor VIII activity in patients with severe haemophilia A.
Matsumoto T; Nogami K; Tabuchi Y; Yada K; Ogiwara K; Kurono H; Arai N; Shima M
Haemophilia; 2017 Sep; 23(5):e427-e435. PubMed ID: 28750470
[TBL] [Abstract][Full Text] [Related]
20. Continuous infusions of B domain-truncated recombinant factor VIII, turoctocog alfa, for orthopedic surgery in severe hemophilia A: first case report.
Takeyama M; Nogami K; Kobayashi R; Ogiwara K; Taniguchi A; Nakanishi Y; Inagaki Y; Tanaka Y; Shima M
Int J Hematol; 2018 Aug; 108(2):199-202. PubMed ID: 29383626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
